Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway

This publication has 43 references indexed in Scilit:

• Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: Involvement of a p38 MAP kinase-dependent mechanism
  Life Sciences, 2001
• Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression
  Clinical Immunology, 2001
• A Cyclopentenone Prostaglandin Activates Mesangial MAP Kinase Independently of PPARγ
  Biochemical and Biophysical Research Communications, 2001
• Role of galectin-3 as a receptor for advanced glycosylation end products
  Kidney International, 2000
• Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells
  Kidney International, 2000
• Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial Cells
  Biochemical and Biophysical Research Communications, 1999
• High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression
  FEBS Letters, 1999
• Effect of Advanced Glycosylation End Products on the Induction of Nitric Oxide Synthase in Murine Macrophages
  Biochemical and Biophysical Research Communications, 1996
• Glycosylation Products as Toxic Mediators of Diabetic Complications
  Annual Review of Medicine, 1991
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988